XiaolinZhangMD
Ophthalmology • Thousand Oaks, CAAnterior Segment Related, Cornea & External Disease, Refractive Surgery
Miramar Eye Specialists Medical Group
Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2230 Lynn Rd
suite 102
Thousand Oaks, CA 91360Phone+1 805-495-0458Fax+1 805-494-9630- Is this information wrong?
Summary
- Dr. Xiaolin Zhang is an ophthalmologist in Thousand Oaks, CA. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 7 years. She specializes in anterior segment related and cornea & external disease and is experienced in corneal transplant surgery, cornea / external disease, dry eye, corneal infections / ulcers, and ocular surface disease.
Education & Training
Albany Medical CenterFellowship, Cornea, External Diseases, and Refractive Surgery, 2014 - 2015
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Ophthalmology, 2010 - 2014
Lehigh Valley Health Network/University of South Florida College of MedicineInternship, Transitional Year, 2010 - 2011
Rutgers Robert Wood Johnson Medical SchoolClass of 2010
Certifications & Licensure
CA State Medical License 2015 - 2024
NY State Medical License 2014 - 2016
OH State Medical License 2011 - 2014
PA State Medical License 2010 - 2011- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 13 citationsSupercritical fluid chromatography-tandem mass spectrometry for high throughput bioanalysis of small molecules in drug discovery.Xiaolin Zhang, Xiao Ding, Jianshuang Wang, Brian Dean> ;Journal of Pharmaceutical and Biomedical Analysis. 2019 Feb 5
- 43 citationsPharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, Christine Orr, Thomas Hunsaker, Matthew R. Durk, Hank La, Xiaolin Zhang, Scott E. Martin, Eva Lin, John Chan, Yihong Yu, Dh...> ;Cancer Cell. 2018 Oct 8
- 14 citationsIndividual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition.Steven Cepa, David Potter, Lisa Wong, Leah Schutt, Jacqueline M. Tarrant, Jodie Pang, Xiaolin Zhang, Roxanne Andaya, Laurent Salphati, Yingqing Ran, Le An, Ryan E. Mor...> ;Toxicology and Applied Pharmacology. 2018 Jan 1
- Join now to see all
Press Mentions
Dizal Reports Positive Phase I Data for Breast Cancer TherapySeptember 6th, 2022- Dizal Announces Sunvozertinib Meets Primary Endpoint in Its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMOSeptember 5th, 2022
- Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Breast Cancer at 2022 ESMOSeptember 5th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
